Babak Abai, MD
Vascular Surgery · Philadelphia, PANPI 1780883371
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Endologix LLC at 46.8% of the total. Among vascular surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $113.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$17K
- Cook Medical LLC$6K
- Bolton Medical Inc$5K
- Medtronic$1K
- W. L. Gore & Associates, Inc.$1K
- Cook Incorporated$1K
- plus $4K from 30 others
What the payments were for
- Consulting fees$14,10038%
- Speaking & faculty fees$1,0203%
- Travel & lodging$4,60713%
- Food & beverage$17,06646%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 39 | $17,217 |
| Cook Medical LLC | 129 | $6,305 |
| Bolton Medical Inc | 17 | $5,151 |
| Medtronic(2 entities) | 31 | $1,323 |
| W. L. Gore & Associates, Inc. | 12 | $1,314 |
| Cook Incorporated | 1 | $1,020 |
| Silk Road Medical, Inc. | 7 | $1,011 |
| Boston Scientific | 11 | $783 |
| Baxter Healthcare | 4 | $235 |
| Abbott | 4 | $216 |
| Penumbra, Inc. | 2 | $198 |
| Novartis | 12 | $184 |
| Johnson & Johnson | 9 | $165 |
| Amgen | 8 | $161 |
| Surmodics, Inc. | 1 | $159 |
| BD | 2 | $145 |
| Philips North America LLC | 1 | $142 |
| Angiodynamics, Inc. | 1 | $127 |
| Shape Memory Medical Inc. | 1 | $125 |
| Cvrx, Inc. | 1 | $122 |
| Inari Medical, Inc. | 2 | $81 |
| AstraZeneca | 3 | $77 |
| Bridgebio Pharma, Inc. | 4 | $73 |
| Abiomed | 3 | $70 |
| Convatec Inc. | 1 | $61 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Misonix Inc | 4 | $55 |
| Boehringer Ingelheim | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Shockwave Medical, Inc | 1 | $27 |
| Heartflow, Inc. | 1 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Merck | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX2 Bifurcated Endograft System$14,361
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$3,029
- Cook$1,517
- TREO ABDOMINAL STENT-GRAFT SYSTEM$1,490
- Alto Abdominal Stent Graft System$1,194
- Zenith Spiral-Z$1,024
- Torus Stent Graft System$957
- ENDOCROSS Device$957
- ENROUTE Transcarotid Neuroprotection System$919
- ENROUTE Transcarotid Stent System$919
- ENHANCE Transcarotid Peripheral Access Kit$919
- ENROUTE 0.014 Guidewire$919
- GORE VIABAHN VBX Balloon Expandable Endo$577
- ELUVIA$432
- ENDURANT IIS$405
- Cook Medical AAA$346
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$307
- HawkOne$270
- Zilver PTX$222
- Pounce Thrombectomy$159
How this compares
$36,793 in reported general payments places this provider in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 14 | $6,857 |
| ClopidogrelClopidogrel Bisulfate | 36 | $546 |
| Cilostazol | 16 | $298 |
| Oxycodone Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $165 | $6,85714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Other vascular surgery in Philadelphia
- Darren SchneiderPhiladelphia$569K
- Elizabeth GenovesePhiladelphia$343K
- Shang LohPhiladelphia$306K
- Edward WooPhiladelphia$58K
- Ann GaffeyPhiladelphia$35K
- Venkat KalapatapuPhiladelphia$31K
- Roberto AruPhiladelphia$30K
- Alexander FairmanPhiladelphia$23K
- Nakul RaoPhiladelphia$22K
- Douglas TroutmanPhiladelphia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.